Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Oric Pharmaceuticals, Inc.

NASDAQ: ORIC · Life Sciences · 5 alerts · CIK 1796280

Share price
$7.52Close, Nov 16
Market cap
$782M
Shares outstanding
103.93MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Oric Pharmaceuticals, Inc. filings on SEC EDGAR ↗

8:01 AM ET 8-K
Clinical Trial Data

Oric Pharmaceuticals Clinical Trial Data

ORIC Pharmaceuticals reported updated Phase 1b data for enozertinib (ORIC-114) in patients with EGFR-mutant non-small cell lung cancer, showing an 84% confirmed systemic objective response rate. The data, presented at the ESMO Congress 2026, also highlighted significant intracranial activity and plans to initiate a global Phase 3 registrational trial in the first half of 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.